In the last trading session, 0.27 million shares of the Rani Therapeutics Holdings Inc (NASDAQ:RANI) were traded, and its beta was 0.09. Most recently the company’s share price was $0.62, and it changed around -$0.03 or -4.83% from the last close, which brings the market valuation of the company to $35.49M. RANI currently trades at a discount to its 52-week high of $5.74, offering almost -825.81% off that amount. The share price’s 52-week low was $0.46, which indicates that the current value has risen by an impressive 25.81% since then.
Rani Therapeutics Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended RANI as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Rani Therapeutics Holdings Inc (NASDAQ:RANI) trade information
Instantly RANI has showed a red trend with a performance of -4.83% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7671 on recent trading dayincreased the stock’s daily price by 19.18%. The company’s shares are currently down -54.98% year-to-date, but still down -3.72% over the last five days. On the other hand, Rani Therapeutics Holdings Inc (NASDAQ:RANI) is -44.93% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $10, which translates to bulls needing to increase their stock price by 93.8% from its current value. Analyst projections state that RANI is forecast to be at a low of $9 and a high of $28.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 4.78%. Rani Therapeutics Holdings Inc earnings are expected to increase by 10.67% in 2025, but the outlook is positive 24.06% per year for the next five years.
RANI Dividends
Rani Therapeutics Holdings Inc’s next quarterly earnings report is expected to be released in June.
NAN FUNG GROUP HOLDINGS LTD, with 1.8959% or 0.49 million shares worth $1.88 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 518.7 shares worth $0.32 million, making up 1.55% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 172.98 shares worth around $0.11 million, which represents about 0.52% of the total shares outstanding.
